Extended Data Fig. 3: eGFR in subset of participants. | Nature Medicine

Extended Data Fig. 3: eGFR in subset of participants.

From: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Extended Data Fig. 3

Change in eGFR in 47 participants with iohexol measured GFR. The effect of semaglutide compared to placebo on estimated GFR was calculated using a MMRM model with two-sided P-values and with fixed effects for treatment, visit, baseline log-transformed UACR, the interaction between treatment and visit, and the interaction between baseline and estimated GFR. Numbers in the lower panel represent the numbers contributing to the mean.

Back to article page